Can a Spur-Shaped stent fix Re-Blocked arteries?

NCT ID NCT06117150

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This pilot study tests a new type of stent—a drug-coated, spur-shaped device—as a primary treatment for in-stent restenosis, where a previously placed coronary artery narrows again. The trial enrolls up to 9 adults with this condition to see if the device is safe in the short term, specifically whether it avoids major heart-related complications during the hospital stay. The goal is to explore whether this design can improve outcomes for patients whose stents have re-blocked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a drug-eluting coronary spur stent system
What this could lead to
If successful, this stent design could offer a better way to treat re-narrowed arteries after a previous stent placement.
What could go wrong
This is a very early pilot study with only 9 participants, so results may not apply broadly. Risks include major cardiac events like heart attack or need for repeat procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IN-STENT RESTENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Auckland City Hospital Te Toka Tumai

    Auckland, Grafton, 1142, New Zealand

  • Wellington Hospital | Capital, Coast and Hutt Valley

    Wellington, Wellington Region, 6023, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.